STA-9090

ganetespib · Synta Pharmaceuticals Corp.

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for STA-9090, covering 2014-09-18 to 2023-11-02. Get the full timeline:

Most recent: Clinical Trial Update: STA-9090 in Previously Treated Patients With Advanced Esophagogastric Cancer [Phase 2]